You are here

Nurses Develop Tool to Reduce Hospital Readmissions

Form identifies high-risk patients

Nurses at California Hospital Medical Center in Los Angeles have created a new tool to help reduce hospital readmissions, according to a report posted on

“We were looking for a way to improve on our generic readmission checklist that is completed on a patient’s admission to the hospital,” said nurse manager Gladys Castro, RN. “The medical/surgical unit has the highest volume of readmissions, so we formed a committee to develop a tool that would identify risk factors for patient readmission.”

Within two weeks the committee had developed a high-risk readmission form, which is filled out during a patient’s admission to the hospital. The tool includes questions that assess each patient’s mobility, risk of falls, whether they use oxygen, age, and other factors. If a patient is identified as being at high risk for readmission, then the admitting nurse will put in an order for a case manager to review the case.

More than a year after its introduction, the readmission form has shown promising results, Castro said. Staff compliance has risen from 33% when the form was first introduced to 98%.

The high-risk readmission form is also used during the medical/surgical staff’s morning huddles to address any issues or problems that may have surfaced since a patient was first admitted.

“As part of our commitment to patient-centered care, we are using the form to look at what the patients need upon admission to the hospital, whether it’s chronic-disease education, oxygen, or help getting to their appointments or getting their medications filled,” Castro said.

Source:; December 23, 2015.

More Headlines

First and Only Treatment Reduces Depressive Symptoms Within Days
Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Combination of Two Drugs Could Reduce Tumor Growth
Pre-clinical Trials Showed Drug Inhibits Fibroblast Activity and Collagen Deposition
PARG Inhibitor Exploits Weakness, Kills Cells
Inexpensive, Wearable Therapy Increases Arm Mobility, Reduces Stiffness
Atezolizumab in Combination with Chemotherapy is the Only First-line Cancer Immunotherapy for ES-SCLC
National Statistics Report Factors In Race, Ethnicity for the First Time